购物车
- 全部删除
- 您的购物车当前为空
NSC348884 是一种核磷蛋白抑制剂,可破坏寡聚体形成并诱导细胞凋亡,在不同的癌细胞系中以 IC50 为 1.7-4.0 μM 抑制细胞增殖。
为众多的药物研发团队赋能,
让新药发现更简单!
NSC348884 是一种核磷蛋白抑制剂,可破坏寡聚体形成并诱导细胞凋亡,在不同的癌细胞系中以 IC50 为 1.7-4.0 μM 抑制细胞增殖。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 233 | 现货 | |
2 mg | ¥ 329 | 现货 | |
5 mg | ¥ 538 | 现货 | |
10 mg | ¥ 955 | 现货 | |
25 mg | ¥ 1,890 | 现货 | |
50 mg | ¥ 3,130 | 现货 | |
100 mg | ¥ 4,530 | 现货 | |
500 mg | ¥ 9,520 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 756 | 现货 |
产品描述 | NSC348884 is a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis, inhibits cell proliferation at an IC50 of 1.7-4.0 μM in distinct cancer cell lines. |
靶点活性 | Nucleophosmin:1.7-4.0 μM |
体外活性 | NSC348884 disrupts a defined hydrophobic pocket required for oligomerization. NSC348884 disrupts nucleophosmin oligomer formation by native polyacrylamide gel electrophoresis assay. NSC348884 upregulates p53. NSC348884 induces apoptosis. |
体内活性 | In vivo invasion and intravasation (that is, the number of CTCs) are significantly inhibited after injection of NSC348884(as an inhibitor of NPM1 oligomerization) into the tumor-bearing mice. No significant difference in overall cell death is observed by histology in the treated tumors with the 4-hour brief treatments, suggesting that the inhibition seen is specific to migration.[2]. |
别名 | N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺 |
分子量 | 636.79 |
分子式 | C38H40N10 |
CAS No. | 81624-55-7 |
Smiles | Cc1ccc2nc(CN(CCN(Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)Cc3nc4ccc(C)cc4[nH]3)[nH]c2c1 |
密度 | 1.347g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (78.52 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容